Individuals struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, copyright, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. Thi